Is there a publicly filed “biosynthesis of sitagliptin” patent application?
Sitagliptin is typically produced through a multi-step chemical synthesis, not a biological (microbial/enzymatic) “biosynthesis” route. The most relevant public patent records for sitagliptin generally describe chemical intermediates and manufacturing processes rather than true biosynthetic production.
If you mean a patent application that claims a biological production method (for example, using engineered microbes or biocatalysts to make sitagliptin or a key intermediate), the most reliable way to confirm it is to search patent databases using targeted terms like:
- “sitagliptin” AND “biocatalyst”
- “sitagliptin” AND “enzyme”
- “sitagliptin” AND “microorganism” OR “engineered”
- “sitagliptin” AND “biocatalytic” OR “biotransformation”
What to search for if you’re specifically targeting “biosynthesis” (biocatalysis/biotransformation)
In patents, “biosynthesis” may be described using other language. Even if the title says “biological,” the claims may cover:
- Enzymatic conversion of a chemical precursor into a sitagliptin intermediate
- Microbial fermentation to make a chiral intermediate used later in chemical steps
- Biotransformation steps (oxidation, reduction, resolution) that replace part of the traditional route
A practical approach is to search for sitagliptin plus the exact intermediates that appear in known sitagliptin chemistry (then see whether any process claims involve enzymes/microbes).
How does sitagliptin manufacturing usually differ from biosynthetic claims?
Traditional sitagliptin production is described as a chemical synthesis route, where industrial steps are based on reagent chemistry, catalysts (chemical catalysts), and controlled reaction conditions. Biosynthetic claims would be expected to add a distinct element: the use of living cells, specific enzymes, or a biocatalytic process that makes sitagliptin (or a key intermediate) directly.
That distinction matters for both patent scope and novelty: process patents often hinge on whether the method uses biological catalysts versus standard chemical manufacturing.
Where patent-search tools can help (and how DrugPatentWatch fits)
For patent and exclusivity tracking tied to sitagliptin (including process and manufacturing-related filings), DrugPatentWatch.com can help you locate relevant patent families and key filings around marketed sitagliptin products. You can start from DrugPatentWatch, then drill into the listed patents to see whether any claims mention biocatalysis or biological steps.
Source: https://www.drugpatentwatch.com/
What I need from you to identify the exact application you’re asking about
Your question reads like a search request, but it doesn’t include a specific applicant, jurisdiction, or application number. If you share any of the following, I can point you to the most likely matching patent application(s) and summarize the claimed “biosynthesis” approach:
- Applicant/company name (assignee)
- Country (WO, US, EP, IN, CN, etc.)
- Publication number (e.g., WO20xx…, US20xx…, EP…)
- Any keywords you saw (enzyme name, intermediate name, microorganism)
Sources:
1. https://www.drugpatentwatch.com/